Hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention in the United States are substantially higher than Medicare payments
- PMID: 25336401
- PMCID: PMC6711053
- DOI: 10.1002/clc.22341
Hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention in the United States are substantially higher than Medicare payments
Abstract
Background: Acute coronary syndromes account for half of all deaths secondary to cardiovascular disease and represent a significant economic burden in the United States. Therefore, assessing hospitalization costs relative to Medicare reimbursement for these patients is important in understanding the impact of these patients on hospitals. We hypothesized that hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention (PCI) were higher than their associated Medicare payments.
Methods: Using the Nationwide Inpatient Sample, we evaluated hospitalization costs for patients treated with PCI from 2001 through 2009 by multiplying hospital charges by the group average cost-to-charge ratio for each patient's hospitalization. Primary end points examined were total hospital costs and trends over time, which were correlated with clinical outcomes and insurance payments. Costs were inflation adjusted with 2009 as the reference year.
Results: Median hospitalization costs of PCI increased from $15 889 (interquartile range [IQR] = $12 057-$21 204) in 2001 to $19 349 (IQR = $14 660-$26 282) in 2009. From 2004 to 2009, inflation-adjusted costs for PCI decreased at a rate of 0.3% per year. In 2009, a total of 265,531 patients received PCI for acute myocardial infarction. Of these, 143 654 were <65 years old, and 121 876 were ≥65 years old. Average 2009 Medicare payments ranged from $9303 to $17 500 depending on the Medicare Severity-Diagnosis Related Groups (MS-DRG) billed, leaving hospitals at a loss of anywhere from $4493 to $7940 per patient when comparing costs and reimbursements across all included MS-DRG codes.
Conclusions: Hospitalization costs for patients treated with PCI have been stabilizing over the last few years; however, there still remains a significant disparity between Medicare reimbursements and hospitalization costs, which has potential implications on patient outcomes, quality of care, and hospital sustainability.
© 2014 Wiley Periodicals, Inc.
Figures
Similar articles
-
Drivers of Variation in 90-Day Episode Payments After Percutaneous Coronary Intervention.Circ Cardiovasc Interv. 2019 Jan;12(1):e006928. doi: 10.1161/CIRCINTERVENTIONS.118.006928. Circ Cardiovasc Interv. 2019. PMID: 30608883 Free PMC article.
-
Implications of Payment for Acute Myocardial Infarctions as a 90-Day Bundled Single Episode of Care: A Cost of Illness Analysis.Pharmacoecon Open. 2022 Nov;6(6):799-809. doi: 10.1007/s41669-022-00328-4. Epub 2022 Feb 28. Pharmacoecon Open. 2022. PMID: 35226305 Free PMC article.
-
Cost-Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease and Acute Coronary Syndromes in the US Medicare Program.J Am Heart Assoc. 2021 Apr 6;10(7):e019391. doi: 10.1161/JAHA.120.019391. Epub 2021 Mar 31. J Am Heart Assoc. 2021. PMID: 33787323 Free PMC article.
-
Impact of Medicare's Bundled Payments Initiative on Patient Selection, Payments, and Outcomes for Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.Circ Cardiovasc Qual Outcomes. 2020 Sep;13(9):e006171. doi: 10.1161/CIRCOUTCOMES.119.006171. Epub 2020 Sep 1. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32867514 Free PMC article.
-
Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.JACC Cardiovasc Interv. 2017 Feb 27;10(4):342-351. doi: 10.1016/j.jcin.2016.11.049. JACC Cardiovasc Interv. 2017. PMID: 28231901
Cited by
-
Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention.JAMA Netw Open. 2024 Feb 5;7(2):e2356078. doi: 10.1001/jamanetworkopen.2023.56078. JAMA Netw Open. 2024. PMID: 38353949 Free PMC article.
-
Collagen matricryptin promotes cardiac function by mediating scar formation.Life Sci. 2023 May 15;321:121598. doi: 10.1016/j.lfs.2023.121598. Epub 2023 Mar 22. Life Sci. 2023. PMID: 36963720 Free PMC article.
-
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.Cancers (Basel). 2020 Jul 17;12(7):1929. doi: 10.3390/cancers12071929. Cancers (Basel). 2020. PMID: 32708835 Free PMC article.
-
Early vs Late Discharge in Low-Risk ST-Elevation Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.Cardiovasc Revasc Med. 2020 Nov;21(11):1360-1368. doi: 10.1016/j.carrev.2020.04.030. Epub 2020 May 1. Cardiovasc Revasc Med. 2020. PMID: 32473910 Free PMC article.
-
Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry.J Am Heart Assoc. 2019 Apr 16;8(8):e011322. doi: 10.1161/JAHA.118.011322. J Am Heart Assoc. 2019. PMID: 30975005 Free PMC article.
References
-
- Kochanek KD, Xu JQ, Murphy SL, et al. Deaths: preliminary data for 2009. Natl Vital Stat Rep. 2011;59:1–51. - PubMed
-
- Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care. 2009;15:S36–S41. - PubMed
-
- Agency for Healthcare Research and Quality . Healthcare Cost and Utilization Project. Nationwide Inpatient Sample. 2001‐2009. http://www.hcup‐us.ahrq.gov/nisoverview.jsp. (accessed December 31, 2012).
-
- Agency for Healthcare Research and Quality . Healthcare Cost and Utilization Project. Cost‐to‐charge ratio files. August 2011. http://www.hcup‐us.ahrq.gov/db/state/costtocharge.jsp. (accessed December 31, 2012).
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
